Comparison of neoadjuvant regimens for resectable gastroesophageal junction cancer: a systematic review of randomized clinical trials across three decades.

Nishikawa, Go; Banik, Pratyusha; Thawani, Rajat; Kardosh, Adel; Wood, Stephanie G; Nabavizadeh, Nima; Chen, Emerson Y

Nishikawa, Go; Banik, Pratyusha; Thawani, Rajat; Kardosh, Adel; Wood, Stephanie G; Nabavizadeh, Nima; Chen, Emerson Y.

Afiliação

Nishikawa G; Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
Banik P; Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
Thawani R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Kardosh A; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Wood SG; Division of Gastrointestinal and General Surgery, Oregon Health & Science University, Portland, OR, USA.
Nabavizadeh N; Department of Radiation Medicine, Oregon Health & Science University, Portland, OR, USA.
Chen EY; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.

J Gastrointest Oncol ; 13(3): 1454-1466, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35837173

Palavras-chave

Gastric cancer; esophageal cancer; gastroesophageal junction (GEJ) cancer; neoadjuvant chemotherapy (CT); neoadjuvant radiation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos